David Meyer, MD
Critical Care Medicine · Houston, TXNPI 1861704850
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 47 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations.
Across 47 payments — averaging $33.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- LEO Pharma Inc.$269
- Zimmer Biomet$158
- Smith+Nephew$140
- Galderma Laboratories, L.p.$123
- Baxter Healthcare$111
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$111
- plus $642 from 12 others
Across 3 payments — averaging $4211.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- CSL Behring$13K
What the payments were for
- Food & beverage$1,554100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| LEO Pharma Inc. | 12 | $269 |
| Zimmer Biomet | 3 | $158 |
| Smith+Nephew | 1 | $140 |
| Galderma Laboratories, L.p. | 2 | $123 |
| Baxter Healthcare | 1 | $111 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $111 |
| KCI USA, Inc. | 1 | $104 |
| Acell, Inc. | 1 | $88 |
| DUSA Pharmaceuticals, Inc. | 4 | $82 |
| TELA Bio, Inc. | 3 | $71 |
| Incyte Corporation | 3 | $52 |
| Almirall LLC | 3 | $48 |
| Wound Management Technologies, Inc | 1 | $45 |
| Aroa Biosurgery Incorporated | 1 | $42 |
| Biofrontera Inc. | 1 | $42 |
| Johnson & Johnson | 2 | $28 |
| Novo Nordisk | 1 | $20 |
| Sun Pharmaceutical Industries Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REAL INTELLIGENCE$140
- Walter$121
- FLOSEAL$111
- DYSPORT$110
- VAC VERAFLO$104
- ABTHERA$104
- PREVENA$104
How this compares
$1,554 in reported general payments places this provider in the 70th percentile of 507 critical care medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Houston
- Edwin ParsleyHouston$283K
- Bindu AkkantiHouston$185K
- Faisal MasudHouston$155K
- Sergio Trevino CastilloHouston$133K
- Sami HossriHouston$34K
- George WilliamsHouston$33K
- Nicholas VillalobosHouston$26K
- Ranjan UpadhyayHouston$25K
- Deepa GoturHouston$23K
- Hany Abd-El MalekHouston$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.